Comparison of Two Qualia NAD⁺ Formulations on Intracellular NAD⁺ Levels
NCT ID: NCT07132801
Last Updated: 2025-08-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
180 participants
INTERVENTIONAL
2025-10-13
2025-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Qualia NAD+ Supplementation on Intracellular NAD Levels
NCT06505967
Effectiveness of Qualia NAD+ Supplementation on NAD Levels
NCT06812416
Effects of NAD3 Supplementation on Biomarkers of Aging
NCT04276948
Absorption and Tolerability of Injectable Administration of Niagen®+, as Compared to NAD+
NCT06919328
IV Administration of ChromaDex's Niagen® as Compared to NAD+
NCT06382688
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Qualia NAD⁺ version 1
Qualia NAD⁺ version 1
Qualia NAD+ version 1 manufactured by Qualia Life Sciences
Qualia NAD⁺ version 2
Qualia NAD⁺ version 2
Qualia NAD+ version 2 manufactured by Qualia Life Sciences
Placebo
Placebo
Rice Flour
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Qualia NAD⁺ version 1
Qualia NAD+ version 1 manufactured by Qualia Life Sciences
Qualia NAD⁺ version 2
Qualia NAD+ version 2 manufactured by Qualia Life Sciences
Placebo
Rice Flour
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Healthy male and female participants aged 35-75 years Willing to self-administer the intracellular NAD⁺ finger-stick test at home (baseline and Day 28) Willing to avoid supplements, energy drinks/shots, or other products containing niacin, niacinamide, nicotinamide riboside, or NMN for ≥ 2 weeks before baseline and throughout the study
Exclusion Criteria
35 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Qualia Life Sciences
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Qualia Life Sciences
Carlsbad, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
QLS-014
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.